WASHINGTON (AP) — The Social Security Administration ‘s acting commissioner has stepped down from her role at the agency over Department of Government Efficiency requests to access Social Security recipient information, according to two people familiar with the official’s departure who were not authorized to discuss the matter publicly.

Acting Commissioner Michelle King's departure from the agency over the weekend — after more than 30 years of service — was initiated after King refused to provide DOGE staffers at the SSA with access to sensitive information, the people said Monday.

The White House has replaced her as acting commissioner with Leland Dudek, who currently works at the SSA, the people said.

White House spokesperson Harrison Fields released a statement Monday night saying: “President Trump has nominated the highly qualified and talented Frank Bisignano to lead the Social Security Administration, and we expect him to be swiftly confirmed in the coming weeks. In the meantime, the agency will be led by a career Social Security anti-fraud expert as the acting commissioner."

Fields added, "President Trump is committed to appointing the best and most qualified individuals who are dedicated to working on behalf of the American people, not to appease the bureaucracy that has failed them for far too long.”

King's exit from the administration is one of several departures of high-ranking officials concerned about DOGE staffers' potential unlawful access to private taxpayer information.

DOGE has accessed Treasury payment systems and is attempting to access Internal Revenue Service databases.

Since Republican President Donald Trump has retaken the White House, his billionaire adviser Elon Musk has rapidly burrowed deep into federal agencies while avoiding public scrutiny of his work through the DOGE group.

Nancy Altman, president of Social Security Works, an advocacy group for the preservation of Social Security benefits, said of DOGE's efforts that "there is no way to overstate how serious a breach this is. And my understanding is that it has already occurred.”

“The information collected and securely held by the Social Security Administration is highly sensitive," she said. "SSA has data on everyone who has a Social Security number, which is virtually all Americans, everyone who has Medicare, and every low-income American who has applied for Social Security’s means-tested companion program, Supplemental Security Income."

“If there is an evil intent to punish perceived enemies, someone could erase your earnings record, making it impossible to collect the Social Security and Medicare benefits you have earned.”

The future of Social Security has become a top political issue and was a major point of contention in the 2024 election. About 72.5 million people, including retirees, disabled people and children, receive Social Security benefits.

Share:
More In Politics
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More